Why wasn't the various failed results you cite raised by any analyst at the Wednesday presentation?
I also "believe" that at the time of his initial acquisition of ZIOP Kirk said his interest in ZIOP had nothing to do with the potential for Pali but was entirely based on his expectations of the success of the type of testing they are engaged in now. He described the future potential revenue of a successful Pali approval as merely being a "rounding off figure" to that generated by their other products.
That was an extraordinary, impressive statement by Dr. Cooper. Wow!
Is it possible that the incessant favorable propagandists are really hedge fund shills looking to short at a higher price, and that the incessant negative propagandists are hedge fund shills looking to buy at a lower price?
Recent news about Acusphere being sued for legal fees by Celgene makes me wonder where the resources to pay a top tier law firm like Goodwin Proctor to defend you comes from. I guess Teva must be footing the bill.
As much as I an optimistic about the prospects of their current science I still have memories of the shock when Pali testing was abandoned and the stock plummeted. There had been just as great a build up of expectations preceding this, accompanied by significant shorting advocates who were resoundingly proved correct. There are huge expectations of success built into the current stock price.
My decent sized position in ZIOP has grown in the last 10 months to be by far my single largest holding. I remain optimistic with memories of Pali creating apprehension.
I believe the expression "rearranging the deck chairs on the Titanic" might explain the volume. Your final sentence probably expressed the prevailing sentiment of most people.